• NEBANNER

Featured

  • 2021 New Style Manganese Removal From Water - 2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile – JIN DUN

    2021 New Style Manganese Removal From Water - 2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile – JIN DUN

    2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile is used as the intermediate of Trelagliptin succinate . Trogliptin succinate is a dipeptidyl peptidase Ⅳ (DPP – Ⅳ) inhibitor developed by Takeda (Takeda Pharmaceutical Co., Ltd.) in Japan. It can selectively and continuously inhibit DPP – Ⅳ and control blood glucose level. Clinical trials show that the drug has good safety and effectiveness. Once a week can effectively control the blood glu...
  • Factory Cheap Hot Hydrogen Peroxide Water Treatment System - 7,10-o-ditroc docetaxel – JIN DUN

    Factory Cheap Hot Hydrogen Peroxide Water Treatment System - 7,10-o-ditroc docetaxel – JIN DUN

    7,10-o-ditroc docetaxel is used as the intermediate of Docetaxel Docetaxel is suitable for the treatment of locally advanced or metastatic breast cancer. Docetaxel is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer, even after the failure of cisplatin based chemotherapy.
  • 18 Years Factory Ion Exchange System - 2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid – JIN DUN

    18 Years Factory Ion Exchange System - 2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid – JIN DUN

    2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid is used as the intermediate of Eltrombopag . Eltrombopag, developed by GlaxoSmithKline (GSK) in the UK and later jointly developed with Novartis in Switzerland, is the first and only approved small molecule non peptide TPO receptor agonist in the world. Eltrombopag was approved by the US FDA in 2008 for the treatment of idiopathic thrombocytopenic purpura (ITP), and in 2014 for the treatment of severe aplastic anemia (AA). It is also ...
  • Quality Inspection for Industrial Reverse Osmosis - ( R )-2,3-o-isopropylidene-glyceraldehyde – JIN DUN

    Quality Inspection for Industrial Reverse Osmosis - ( R )-2,3-o-isopropylidene-glyceraldehyde – JIN DUN

    ( R )-2,3-o-isopropylidene-glyceraldehyde is used as the intermediate of Gemcitabine. Gemcitabine is a pyrimidine nucleotide analogue, which belongs to anti metabolic anticancer drugs. It can prevent the progress of DNA synthesis in a certain period, that is, S-phase. It has the characteristics of wide anticancer spectrum, unique mechanism of action, low toxicity, no cross resistance with other chemotherapeutic drugs and no superposition of toxicity. Today, gemcitabine has been approved for u...
  • High definition Risperidone Generic - ( R )-2,3-o-isopropylidene-glyceraldehyde – JIN DUN

    High definition Risperidone Generic - ( R )-2,3-o-isopropylidene-glyceraldehyde – JIN DUN

    ( R )-2,3-o-isopropylidene-glyceraldehyde is used as the intermediate of Gemcitabine. Gemcitabine is a pyrimidine nucleotide analogue, which belongs to anti metabolic anticancer drugs. It can prevent the progress of DNA synthesis in a certain period, that is, S-phase. It has the characteristics of wide anticancer spectrum, unique mechanism of action, low toxicity, no cross resistance with other chemotherapeutic drugs and no superposition of toxicity. Today, gemcitabine has been approved for u...
  • High Performance Polyaluminum Chloride Coagulant - R-Tetrahydropapaverine N-acetyl-L-leucinate – JIN DUN

    High Performance Polyaluminum Chloride Coagulant - R-Tetrahydropapaverine N-acetyl-L-leucinate – JIN DUN

    Tetrahydropapaverine hydrochloride is used as the intermediate of Cisatracurium besylate . Cisatracurium besylate is the benzene sulfonate salt form of atracurium. It is a kind of artificially synthetic non-depolarizing muscle relaxants with its role similar as tubocurarine. It has an onset time of 1 minute and duration time of 15 minutes. The treatment dose does not affect the heart, liver and kidney function. It also has no accumulation property. It also can induce the release of histamine ...
  • Factory Promotional Ziprasidone Hydrochloride - 7-ethyl-10-(chlorocarbonyloxy)camptothe cin – JIN DUN

    Factory Promotional Ziprasidone Hydrochloride - 7-ethyl-10-(chlorocarbonyloxy)camptothe cin – JIN DUN

    7-ethyl-10-(chlorocarbonyloxy)camptothe cin is used as the intermediate of Irinotecan. Irinotecan antitumor drug. It is an inhibitor of DNA synthesis. It is a semi synthetic derivative of camptothecin; Used for preparing irinotecan hydrochloride and irinotecan hydrochloride trihydrate; Large scale clinical trials have shown that irinotecan hydrochloride has obvious inhibitory effects on a variety of tumors, such as colon cancer, small cell lung cancer, rectal cancer and leukemia, and is still...
  • Factory Price High Pressure Catalytic Hydrogenation - 2-deoxy-2,2-difluoro-3,5-o-dibenzoylribose mesylate – JIN DUN

    Factory Price High Pressure Catalytic Hydrogenation - 2-deoxy-2,2-difluoro-3,5-o-dibenzoylribose mesylate – JIN DUN

    2-deoxy-2,2-difluoro-3,5-o-dibenzoylribose mesylate is used as the intermediate of Gemcitabine. Gemcitabine is a pyrimidine nucleotide analogue, which belongs to anti metabolic anticancer drugs. It can prevent the progress of DNA synthesis in a certain period, that is, S-phase. It has the characteristics of wide anticancer spectrum, unique mechanism of action, low toxicity, no cross resistance with other chemotherapeutic drugs and no superposition of toxicity. Today, gemcitabine has been appr...
  • Best-Selling Neuroleptic Treatment - 2-deoxy-2,2-difluoro-d-ribofuranose-3,5-dib enzoate – JIN DUN

    Best-Selling Neuroleptic Treatment - 2-deoxy-2,2-difluoro-d-ribofuranose-3,5-dib enzoate – JIN DUN

    2-deoxy-2,2-difluoro-d-ribofuranose-3,5-dib enzoate is used as the intermediate of Gemcitabine . Gemcitabine is a pyrimidine nucleotide analogue, which belongs to anti metabolic anticancer drugs. It can prevent the progress of DNA synthesis in a certain period, that is, S-phase. It has the characteristics of wide anticancer spectrum, unique mechanism of action, low toxicity, no cross resistance with other chemotherapeutic drugs and no superposition of toxicity. Today, gemcitabine has been app...
  • 2021 High quality Edr Water Treatment - N-acetyl-n,o-bis-(trimethylsilyl)-cytosine – JIN DUN

    2021 High quality Edr Water Treatment - N-acetyl-n,o-bis-(trimethylsilyl)-cytosine – JIN DUN

    N-acetyl-n,o-bis-(trimethylsilyl)-cytosine is used as the intermediate of Gemcitabine. Gemcitabine is a pyrimidine nucleotide analogue, which belongs to anti metabolic anticancer drugs. It can prevent the progress of DNA synthesis in a certain period, that is, S-phase. It has the characteristics of wide anticancer spectrum, unique mechanism of action, low toxicity, no cross resistance with other chemotherapeutic drugs and no superposition of toxicity. Today, gemcitabine has been approved for ...
  • New Delivery for Triclabendazole 68786-66-3 - Tetrahydropapaverine hydrochloride – JIN DUN

    New Delivery for Triclabendazole 68786-66-3 - Tetrahydropapaverine hydrochloride – JIN DUN

    Tetrahydropapaverine hydrochloride is used as the intermediate of Cisatracurium besylate . Cisatracurium besylate is the benzene sulfonate salt form of atracurium. It is a kind of artificially synthetic non-depolarizing muscle relaxants with its role similar as tubocurarine. It has an onset time of 1 minute and duration time of 15 minutes. The treatment dose does not affect the heart, liver and kidney function. It also has no accumulation property. It also can induce the release of histamine ...
  • China wholesale Treatment Of Water - Cyclopropyl 2-fluorobenzyl ketone – JIN DUN

    China wholesale Treatment Of Water - Cyclopropyl 2-fluorobenzyl ketone – JIN DUN

    Cyclopropyl 2-fluorobenzyl ketone is used as the intermediate of Prasugrel . Prasugrel is a thiophenopyridine antiplatelet developed by Eli Lilly and daiichisankyo, a Japanese pharmaceutical manufacturer. It is a precursor drug. It forms an active molecule after metabolism through cytochrome P450 in the liver and combines with platelet P2Y12 receptor to exert an active against platelet aggregation. Clinical studies have proved that 60 mg dose has better anticoagulant effect than 300 mg standa...